Next Article in Journal
Moderate Increase in Protein Intake Promotes a Small Additional Improvement in Functional Capacity, But Not in Muscle Strength and Lean Mass Quality, in Postmenopausal Women Following Resistance Exercise: A Randomized Clinical Trial
Previous Article in Journal
Re: Scragg–Emerging Evidence of Thresholds for Beneficial Effects from Vitamin D Supplementation
Previous Article in Special Issue
Milk Powder Fortified with Potassium and Phytosterols to Decrease the Risk of Cardiovascular Events among the Adult Population in Malaysia: A Cost-Effectiveness Analysis
Open AccessArticle

Plasma Trimethylamine-N-oxide following Cessation of L-carnitine Supplementation in Healthy Aged Women

1
Faculty of Rehabilitation and Kinesiology, Department of Bioenergetics and Nutrition, Gdansk University Physical Education and Sport, Gorskiego 1, 80-336 Gdansk, Poland
2
Mass Spectrometry Laboratory, Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Pawinskiego 5a, 02-106 Warsaw, Poland
*
Author to whom correspondence should be addressed.
Nutrients 2019, 11(6), 1322; https://doi.org/10.3390/nu11061322
Received: 13 May 2019 / Revised: 31 May 2019 / Accepted: 11 June 2019 / Published: 13 June 2019
(This article belongs to the Special Issue Nutritional Determinants and Cardiovascular Disease)
L-carnitine supplementation elevates plasma trimethylamine-N-oxide (TMAO), which may participate in atherosclerosis development by affecting cholesterol metabolism. The aim of the current study was to determine the effect of increased plasma TMAO on biochemical markers in the blood following cessation of L-carnitine supplementation. The follow-up measurements were performed on subjects who completed 24 weeks of L-carnitine or placebo supplementation protocol. Blood samples were taken after finishing the supplementation and then 4 and 12 months following the supplementation withdrawal. Four months after cessation of L-carnitine supplementation, plasma TMAO concentration reached a normal level which was stable for the following eight months. During this period, no modifications in serum lipid profile and circulating leukocyte count were noted. TMAO implications in health and disease is widely discussed. The results of this study demonstrate no adverse effects of elevated plasma TMAO, induced by L-carnitine, on the measured parameters at 4 and 12 months after withdrawal of supplementation. View Full-Text
Keywords: cardiovascular disease; endothelial dysfunction; atherosclerosis; cholesterol; leukocytes cardiovascular disease; endothelial dysfunction; atherosclerosis; cholesterol; leukocytes
Show Figures

Figure 1

MDPI and ACS Style

Samulak, J.J.; Sawicka, A.K.; Samborowska, E.; Olek, R.A. Plasma Trimethylamine-N-oxide following Cessation of L-carnitine Supplementation in Healthy Aged Women. Nutrients 2019, 11, 1322.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map

1
Nutrients, EISSN 2072-6643, Published by MDPI AG
Back to TopTop